USPTO Patent Application for Self-Emulsifying Drug Delivery Systems
Summary
The USPTO has published a patent application from Fertin Pharma A/S for a dosage form utilizing self-emulsifying drug delivery systems (SEDDS) for cannabinoids. The application details specific formulations including surfactants with PEG moieties and isolated or synthetic cannabinoids.
What changed
This document is a USPTO patent application (US20260083757A1) filed by Fertin Pharma A/S, detailing a dosage form for delivering cannabinoids. The formulation incorporates self-emulsifying drug delivery systems (SEDDS) with a significant percentage of polyethylene glycol (PEG) surfactants and at least 10% by weight of isolated or synthetic cannabinoids.
As this is a patent application, it does not impose immediate regulatory obligations. However, it signifies potential future developments in cannabinoid drug delivery systems. Companies operating in the pharmaceutical and cannabinoid sectors should be aware of this application as it may impact future product development and intellectual property landscapes. The filing date was September 20, 2024, with a publication date of March 26, 2026.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Dosage Forms For Delivery Of Self-Emulsifying Drug Delivery Systems
Application US20260083757A1 Kind: A1 Mar 26, 2026
Assignee
Fertin Pharma A/S
Inventors
Sanne Skov Jensen, Gitte Nykjær Nikolajsen, Benjamin Bugge Wahlqvist
Abstract
A dosage form for delivery of cannabinoids includes a formulation including: one or more self-emulsifying drug delivery systems (SEDDS) including one or more surfactants having a chemical structure that includes a polyethylene glycol (PEG) moiety in an amount of at least 30% by weight of the one or more SEDDS; and one or more cannabinoids including one or more isolated or synthetic cannabinoids in an amount of at least 10% by weight of the formulation.
CPC Classifications
A61K 31/658 A61K 9/107 A61K 47/10 A61K 47/14 A61K 47/44
Filing Date
2024-09-20
Application No.
18891058
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.